Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Non-Current Assets: 2022-2025

Historic Other Non-Current Assets for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $12,815.

  • bioAffinity Technologies' Other Non-Current Assets fell 34.87% to $12,815 in Q3 2025 from the same period last year, while for Sep 2025 it was $12,815, marking a year-over-year decrease of 34.87%. This contributed to the annual value of $19,676 for FY2024, which is 22.52% up from last year.
  • As of Q3 2025, bioAffinity Technologies' Other Non-Current Assets stood at $12,815, which was up 0.01% from $12,814 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Other Non-Current Assets ranged from a high of $19,676 in Q3 2024 and a low of $6,000 during Q3 2022.
  • For the 3-year period, bioAffinity Technologies' Other Non-Current Assets averaged around $15,123, with its median value being $16,060 (2024).
  • Per our database at Business Quant, bioAffinity Technologies' Other Non-Current Assets soared by 184.32% in 2024 and then slumped by 34.87% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Other Non-Current Assets stood at $6,000 in 2022, then soared by 167.67% to $16,060 in 2023, then grew by 22.52% to $19,676 in 2024, then tumbled by 34.87% to $12,815 in 2025.
  • Its last three reported values are $12,815 in Q3 2025, $12,814 for Q2 2025, and $19,675 during Q1 2025.